Strata Critical Medical, Inc. (SRTA) Q2 2026 Earnings Call Transcript
Strata Critical Medical is rated a buy, driven by expanding market share, operational efficiencies, and a comprehensive suite of transplant logistics and clinical services. SRTA's asset-light-to-moder